Pacific Shuanglin Bio-pharmacy Co., LTD (SHE: 000403)

Pacific Shuanglin Bio-pharmacy Co., LTD Statistics

Total Valuation

Pacific Shuanglin Bio-pharmacy Co., LTD has a market cap or net worth of CNY 16.74 billion. The enterprise value is 15.56 billion.

Market Cap	16.74B
Enterprise Value	15.56B

Important Dates

The next estimated earnings date is Monday, October 28, 2024.

Earnings Date	Oct 28, 2024
Ex-Dividend Date	Jun 28, 2024

Share Statistics

Pacific Shuanglin Bio-pharmacy Co., LTD has 731.07 million shares outstanding. The number of shares has decreased by -0.15% in one year.

Shares Outstanding	731.07M
Shares Change (YoY)	-0.15%
Shares Change (QoQ)	+0.05%
Owned by Insiders (%)	4.42%
Owned by Institutions (%)	29.47%
Float	263.02M

Valuation Ratios

The trailing PE ratio is 21.00 and the forward PE ratio is 19.74.

PE Ratio	21.00
Forward PE	19.74
PS Ratio	6.07
PB Ratio	2.20
P/FCF Ratio	58.60
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 15.76, with an EV/FCF ratio of 54.47.

EV / Earnings	19.55
EV / Sales	5.65
EV / EBITDA	15.76
EV / EBIT	18.30
EV / FCF	54.47

Financial Position

The company has a current ratio of 3.72, with a Debt / Equity ratio of 0.07.

Current Ratio	3.72
Quick Ratio	2.45
Debt / Equity	0.07
Debt / EBITDA	0.54
Debt / FCF	1.86
Interest Coverage	79.99

Financial Efficiency

Return on equity (ROE) is 10.94% and return on invested capital (ROIC) is 6.84%.

Return on Equity (ROE)	10.94%
Return on Assets (ROA)	6.28%
Return on Capital (ROIC)	6.84%
Revenue Per Employee	1.14M
Profits Per Employee	328,095
Employee Count	2,426
Asset Turnover	0.33
Inventory Turnover	1.31

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +9.37% in the last 52 weeks. The beta is 0.45, so Pacific Shuanglin Bio-pharmacy Co., LTD's price volatility has been lower than the market average.

Beta (5Y)	0.45
52-Week Price Change	+9.37%
50-Day Moving Average	24.07
200-Day Moving Average	26.60
Relative Strength Index (RSI)	47.49
Average Volume (20 Days)	12,069,584

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Pacific Shuanglin Bio-pharmacy Co., LTD had revenue of CNY 2.76 billion and earned 795.96 million in profits. Earnings per share was 1.09.

Revenue	2.76B
Gross Profit	1.42B
Operating Income	850.45M
Pretax Income	899.63M
Net Income	795.96M
EBITDA	980.29M
EBIT	850.45M
Earnings Per Share (EPS)	1.09

Balance Sheet

The company has 1.70 billion in cash and 531.96 million in debt, giving a net cash position of 1.17 billion or 1.60 per share.

Cash & Cash Equivalents	1.70B
Total Debt	531.96M
Net Cash	1.17B
Net Cash Per Share	1.60
Equity (Book Value)	7.61B
Book Value Per Share	10.42
Working Capital	2.50B

Cash Flow

In the last 12 months, operating cash flow was 635.48 million and capital expenditures -349.78 million, giving a free cash flow of 285.70 million.

Operating Cash Flow	635.48M
Capital Expenditures	-349.78M
Free Cash Flow	285.70M
FCF Per Share	0.39

Margins

Gross margin is 51.65%, with operating and profit margins of 30.86% and 28.88%.

Gross Margin	51.65%
Operating Margin	30.86%
Pretax Margin	32.64%
Profit Margin	28.88%
EBITDA Margin	35.57%
EBIT Margin	30.86%
FCF Margin	10.37%

Dividends & Yields

This stock pays an annual dividend of 0.20, which amounts to a dividend yield of 0.85%.

Dividend Per Share	0.20
Dividend Yield	0.85%
Dividend Growth (YoY)	149.23%
Years of Dividend Growth	1
Payout Ratio	27.11%
Buyback Yield	0.15%
Shareholder Yield	1.00%
Earnings Yield	4.76%
FCF Yield	1.71%

Stock Splits

The last stock split was on July 27, 2020. It was a forward split with a ratio of 1.7947843567.

Last Split Date	Jul 27, 2020
Split Type	Forward
Split Ratio	1.7947843567

Scores

Pacific Shuanglin Bio-pharmacy Co., LTD has an Altman Z-Score of 10.18.

Altman Z-Score	10.18
Piotroski F-Score	n/a